Hexima Share Price and Company Fundamentals



Price
$0.387
Change
-0.023 (-5.610%)
52 week
0.14 - 0.5

Last traded: Today at 4:20 AM

Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. The company was incorporated in 1997 and is headquartered in Melbourne, Australia.

Key Metrics

PE ratio

-

PB ratio

19.80

Dividend yield

Beta

-

Market cap

-

Enterprise value

-

Company profile

Primary activitiesResearch and development of plant-derived proteins and peptides for applications as human therapeutics.
Industry / SectorBiotechnology / Healthcare
Websitehttps://www.hexima.com.au
Mailing addressLa Trobe Institute for Molecular Science Level 4,LIMS 2 La Trobe University Melbourne VIC 3086 Australia
Phone / Fax61 3 9479 1210 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

Hexima does not pay dividends.

Company Executives

As of Jan 2022, following are the company executives and directors listed on Hexima.

NameTitleAgeTotal Pay
Mr. Michael D. A. Aldridge B.Sc (Hons)., B.Sc., M.A., MApFinMD, CEO & Exec. Director54790.85k
Ms. Helen MolloyFinancial Controller192.85k
Dr. Nicole van der Weerden B.Sc., Ph.D., BSc (Hons), MBA (MBS)COO & Exec. Director470.41k
Prof. Marilyn A. Anderson AO, B.Sc., BSc (Hons), FAA, FAICD, FTChief Science Officer70100.93k
Dr. Peter J. Welburn Ph.D.Consultant69140.94k
Dr. Neil ForresterVP of Bus. Devel.
Dr. Yolanda GasparHead of Clinical Operations
Dr. Nancy SaccoChief Devel. Officer
Mr. Phillip J. Rose R. Ph, R.Ph.Chief Commercial Officer67
Ms. Leanne RalphCompany Sec.

Profitability and management effectiveness

Profit margin

-168.39%

Operating margin

-169.21%

Return on assets

-63.95%

Return on equity

-964.52%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Hexima is and its enterprise value is .

Companies similar to Hexima (HXL)

Hexima (ASX:HXL) Frequently Asked Questions

1. What is Hexima's Stock Symbol?

Hexima trades on ASX under the ticker symbol "HXL".

2. What is Hexima's stock price today?

One share of HXL stock can currently be purchased for approximately $0.387.

3. How can I contact Hexima?

Hexima's mailing address is La Trobe Institute for Molecular Science Level 4,LIMS 2 La Trobe University Melbourne VIC 3086 Australia. The company can be reached via phone at 61 3 9479 1210.

4. What is Hexima's official website?

The official website of Hexima is https://www.hexima.com.au.

5. Which share registry manages Hexima's stock?

Hexima's stock is managed by LINK MARKET SERVICES LIMITED.